Metformin is one of the most widely prescribed medications in the world. But what exactly is it? More importantly, what do you need to know about it before taking it? Metformin is a drug used to treat type 2 diabetes, but its effects don't just stop there. It has been found to have a variety of other health benefits as well. In this blog post, we'll take a look at metformin, including its maximum dose, potential benefits and possible side effects. With this information in hand, you can make an informed decision about whether or not metformin is right for you.
Metformin is a prescription drug used to treat type 2 diabetes. It is also used to treat polycystic ovarian syndrome (PCOS). Metformin works by decreasing the amount of sugar that your liver produces and your body absorbs. It also helps to make your body more sensitive to insulin. The maximum recommended dose of metformin is 2000 mg per day. Possible side effects of metformin include headache, nausea, vomiting, diarrhea, and abdominal pain.
Metformin is an oral medication used to treat type 2 diabetes. It works by decreasing the amount of sugar produced by the liver and increasing insulin sensitivity. Metformin is usually taken with meals. The maximum recommended dose is 2000 mg per day. Possible side effects include nausea, diarrhea, and headache.
If you have type 2 diabetes, you may be familiar with the oral medication metformin. Metformin is usually the first medication prescribed for type 2 diabetes. It’s also often used in combination with other diabetes medications, such as insulin.
Metformin can help control blood sugar levels by:
-Reducing the amount of sugar your liver makes
-Decreasing the amount of sugar your body absorbs from food
-Increasing insulin sensitivity
In addition to lowering blood sugar levels, metformin has been shown to have other health benefits, including:
-Weight loss
-Lowering cholesterol and triglycerides
-Reducing the risk of heart attack and stroke
-Slowing the progression of kidney disease
The most common side effects of metformin are gastrointestinal and include diarrhea, bloating, flatulence, indigestion, and abdominal discomfort. Nausea and vomiting may also occur. These side effects are usually temporary and improve with continued treatment.
Rare but serious side effects of metformin include lactic acidosis (a build-up of lactic acid in the blood) and hypoglycemia (low blood sugar). Lactic acidosis is a medical emergency that requires immediate treatment. Symptoms of lactic acidosis include abdominal pain, muscle pain, shortness of breath, irregular heartbeat, and dizziness.
Hypoglycemia can also be a serious side effect of metformin. Symptoms of hypoglycemia include confusion, dizziness, headache, blurred vision, hunger, sweating, tremor, and fast heartbeat.
Metformin is a widely used medication that helps manage type 2 diabetes. It can also be prescribed to treat polycystic ovary syndrome (PCOS) and nonalcoholic fatty liver disease (NAFLD). While Metformin has many potential benefits, it's important to understand the possible side effects as well.
1.
Team finds broken 'brake' on cancer mutation machine.
2.
Breast cancer: Why it's difficult to treat and what new approaches are on the horizon
3.
Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy
4.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
5.
Even when they are not paying attention, children are still learning.
1.
Navigating the Complexities of Esophageal Cancer Staging
2.
Cancer Vaccines In India: The Latest Hope In The Fight Against Disease
3.
Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care
4.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
5.
Unlocking The Causes And Risk Factors Of Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation